Neuroendocrine neoplasms revisited—the challenges of reclassifying tumor Barbara Kiesewetter editorial 05 December 2022 Pages: 257 - 258
ASCO update: hepatocellular and cholangiocellular carcinoma Angela Djanani short review Open access 23 November 2022 Pages: 259 - 263
ASCO 2022 update: (neo-)adjuvant treatment of colorectal cancer Gudrun Piringer short review 01 November 2022 Pages: 264 - 268
Best of ASCO 2022—central nervous system tumors Annette LeibetsederAnna S. Berghoff short review Open access 05 November 2022 Pages: 269 - 272
Best of ASCO 2022—bladder cancer Martin Pichler short review Open access 02 November 2022 Pages: 273 - 274
Endometrial cancer: news from ASCO Edgar Petru short review Open access 24 October 2022 Pages: 275 - 277
Essential news of current guidelines: head and neck squamous cell carcinoma Thorsten Fuereder short review Open access 29 October 2022 Pages: 278 - 281
Current standards in the surgical treatment of pancreatic and small intestinal neuroendocrine tumors Ulla KlaiberStefan Stättner short review 13 October 2022 Pages: 282 - 286
From morphology to molecular targets—the pathologist’s view in diagnosing gastroenteropancreatic neuroendocrine neoplasms Hanna HenzingerIva Brcic short review Open access 24 October 2022 Pages: 287 - 293
The NET G3 enigma: dealing with a “new” entity Markus RadererBarbara Kiesewetter short review Open access 25 October 2022 Pages: 294 - 297
Pharmacokinetic drug interactions of oral anticancer drugs Julia Gampenrieder Satory short review 24 October 2022 Pages: 298 - 302
Challenges in integrating molecular profiles into clinical cancer care Stephan W. JahnPhilipp J. Jost short review Open access 06 October 2022 Pages: 303 - 306
Bilateral primary breast lymphoma in a pregnant woman: a case report and literature review Hasan Cagri YildirimArif AkyildizIbrahim Barista case report 04 October 2022 Pages: 307 - 310